Department of Ultrasonic Imaging, the First Hospital of Shanxi Medical University, Taiyuan 030001, China.
Department of Thoracic Surgery, the General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin 150088, China.
Chin J Nat Med. 2021 Nov;19(11):815-824. doi: 10.1016/S1875-5364(21)60106-1.
Cervical cancer (CC) is recognized as the most common neoplasm in the female reproductive system worldwide. The lack of chemotherapeutic agents with outstanding effectiveness and safety severely compromises the anti-cipated prognosis of patients. Aloperine (ALO) is a natural quinolizidine alkaloid with marked anti-cancer effects on multiple malignancies as well as favorable activity in relieving inflammation, allergies and infection. However, its therapeutic efficacy and underlying mechanism in CC are still unclear. In the current study, MTT assay was employed to evaluate the viability of HeLa cells exposed to ALO to preliminarily estimate the effectiveness of ALO in CC. Then, the effects of ALO on the proliferation and apoptosis of HeLa cells were further investigated by plate colony formation and flow cytometry, respectively, while the migration and invasion of ALO-treated HeLa cells were evaluated using Transwell assay. Moreover, nude mice were subcutaneously inoculated with HeLa cells to demonstrate the anti-CC properties of ALO in vivo. The molecular mechanisms underlying these effects of ALO were evaluated by Western blot and immunohistochemical analysis. This study experimentally demonstrated that ALO inhibited the proliferation of HeLa cells via G2 phase cell cycle arrest. Simultaneously, ALO promoted an increase in the percentage of apoptotic HeLa cells by increasing the Bax/Bcl-2 ratio. Additionally, the migration and invasion of HeLa cells were attenuated by ALO treatment, which was considered to result from inhibition of epithelial-to-mesenchymal transition. For molecular mechanisms, the expression and activation of the IL-6-JAK1-STAT3 feedback loop were markedly suppressed by ALO treatment. This study indicated that ALO markedly suppresses the proliferation, migration and invasion and enhances the apoptosis of HeLa cells. In addition, these prominent anti-CC properties of ALO are associated with repression of the IL-6-JAK1-STAT3 feedback loop.
宫颈癌(CC)是全球女性生殖系统中最常见的肿瘤。缺乏高效且安全的化疗药物严重影响了患者的预期预后。阿罗品(ALO)是一种天然喹诺利啶生物碱,对多种恶性肿瘤具有显著的抗癌作用,并具有良好的抗炎、抗过敏和抗感染活性。然而,其在 CC 中的治疗效果和作用机制尚不清楚。在本研究中,采用 MTT 法评估了 ALO 处理的 HeLa 细胞的活力,初步评估了 ALO 在 CC 中的有效性。然后,通过平板集落形成和流式细胞术分别研究了 ALO 对 HeLa 细胞增殖和凋亡的影响,同时通过 Transwell 实验评估了 ALO 处理的 HeLa 细胞的迁移和侵袭。此外,通过皮下接种 HeLa 细胞的裸鼠实验在体内证明了 ALO 的抗 CC 特性。通过 Western blot 和免疫组化分析评估了 ALO 作用的分子机制。本研究实验表明,ALO 通过 G2 期细胞周期阻滞抑制 HeLa 细胞的增殖。同时,ALO 通过增加 Bax/Bcl-2 比值促进凋亡的 HeLa 细胞比例增加。此外,ALO 处理可减弱 HeLa 细胞的迁移和侵袭,这被认为是由于上皮-间充质转化的抑制。对于分子机制,IL-6-JAK1-STAT3 反馈环的表达和激活被 ALO 处理明显抑制。本研究表明,ALO 可显著抑制 HeLa 细胞的增殖、迁移和侵袭,促进凋亡。此外,ALO 的这些显著抗 CC 特性与抑制 IL-6-JAK1-STAT3 反馈环有关。